Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Mouth, Edentulous D009066 1 associated lipids
Pelvic Pain D017699 7 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Uveitis, Anterior D014606 11 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Migraine without Aura D020326 1 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Leukostasis D018921 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Jung TT et al. Effect of inhibitors of leukotriene and/or platelet activating factor on killed H. influenzae induced experimental otitis media with effusion. 2004 Int. J. Pediatr. Otorhinolaryngol. pmid:14687688
Barbanoj MJ et al. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers. 2004 Neuropsychobiology pmid:15539863
Fujii S et al. Chromogenic assay for the activity of sphingomyelinase from Bacillus cereus and its application to the enzymatic hydrolysis of lysophospholipids. 2004 Biol. Pharm. Bull. pmid:15516713
Göggel R et al. PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. 2004 Nat. Med. pmid:14704790
Suenaga A and Ueki H Effect of orthovanadate on platelet aggregation induced by platelet-activating factor. 2004 Biol. Pharm. Bull. pmid:15516737
Tsutsumi T et al. Phorbol myristate acetate stimulates degradation of a structural analogue of platelet-activating factor to a neutral lipid in human leukemic K562 cells: relevance to the release of lipids. 2004 Biol. Pharm. Bull. pmid:14709893
Nakagawa K et al. Sperm-immobilizing antibodies suppress an increase in the plasma membrane fluidity of human spermatozoa. 2004 Fertil. Steril. pmid:15474073
Nie ZG et al. [Effects of ginkgolide B on lipopolysaccharide-induced TNFalpha production in mouse peritoneal macrophages and NF-kappaB activation in rat pleural polymorphonuclear leukocytes]. 2004 Yao Xue Xue Bao pmid:15491096
Besana A et al. Activation of protein kinase C epsilon inhibits the two-pore domain K+ channel, TASK-1, inducing repolarization abnormalities in cardiac ventricular myocytes. 2004 J. Biol. Chem. pmid:15184378
Michail S and Abernathy F A new model for studying eosinophil migration across cultured intestinal epithelial monolayers. 2004 J. Pediatr. Gastroenterol. Nutr. pmid:15187782
Lu H and Xue XD [Platelet-activating factor and neonatal necrotizing enterocolitis]. 2004 Zhonghua Er Ke Za Zhi pmid:15189692
Seyffarth G et al. Lipopolysaccharide induces nitric oxide synthase expression and platelet-activating factor increases nitric oxide production in human fetal membranes in culture. 2004 Reprod. Biol. Endocrinol. pmid:15191613
Lekka ME et al. The impact of intravenous fat emulsion administration in acute lung injury. 2004 Am. J. Respir. Crit. Care Med. pmid:14656749
Buduneli E et al. Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats. 2004 J. Periodontol. pmid:15633329
Vardar S et al. Therapeutic versus prophylactic plus therapeutic administration of omega-3 fatty acid on endotoxin-induced periodontitis in rats. 2004 J. Periodontol. pmid:15732866
Ranasinghe S and Bolsover S Microglial calcium responses to platelet-activating factor are inhibited by analogue CAS 99103-16-9 and dihydropyridine PCA 4248 but not by ginkgolide A. 2004 Basic Clin. Pharmacol. Toxicol. pmid:15379786
Rothhut B Benveniste's reputation was not written in water. 2004 Nature pmid:15565124
Morita K et al. Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice. 2004 Pain pmid:15363879
Serradji N et al. Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity. 2004 J. Med. Chem. pmid:15566310
Nemcsik J et al. Synergistic interaction of endogenous platelet-activating factor and vasopressin in generating angina in rats. 2004 Eur. J. Pharmacol. pmid:15363995
Roudebush WE et al. Exposure of preimplantation embryos to platelet-activating factor increases birth rate. 2004 J. Assist. Reprod. Genet. pmid:15568330
Zinchuk O et al. Dynamics of PAF-induced conjunctivitis reveals differential expression of PAF receptor by macrophages and eosinophils in the rat. 2004 Cell Tissue Res. pmid:15290234
Tarricone C et al. Coupling PAF signaling to dynein regulation: structure of LIS1 in complex with PAF-acetylhydrolase. 2004 Neuron pmid:15572112
Ma YQ et al. P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. 2004 Blood pmid:15217824
Du YM et al. Effects of platelet activating factor on action potentials and potassium channels in guinea-pig ventricular myocytes. 2004 Sheng Li Xue Bao pmid:15224138
Pédrono F et al. Natural 1-O-alkylglycerols reduce platelet-activating factor-induced release of [3H]-serotonin in rabbit platelets. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:15172680
Zimmerman GA and McIntyre TM PAF, ceramide and pulmonary edema: alveolar flooding and a flood of questions. 2004 Trends Mol Med pmid:15177186
Lee SH et al. Role of messenger RNA expression of platelet activating factor and its receptor in porcine in vitro-fertilized and cloned embryo development. 2004 Biol. Reprod. pmid:15151927
Ishii S et al. Platelet-activating factor receptor develops airway hyperresponsiveness independently of airway inflammation in a murine asthma model. 2004 J. Immunol. pmid:15153532
Buke AC et al. Tumor necrosis factor alpha and interleukin 6 productions in response to platelet-activating factor in chronic hepatitis B virus infection. 2004 Sep-Oct Med Princ Pract pmid:15316260
Lemieux C et al. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. 2005 Blood pmid:15498854
Mishra RK et al. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K). 2005 Allergy pmid:16076309
Jin Y et al. Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor. 2005 Eur. J. Immunol. pmid:16078278
Meyer MC et al. Potential role for mast cell tryptase in recruitment of inflammatory cells to endothelium. 2005 Am. J. Physiol., Cell Physiol. pmid:16079184
Fernandes ES et al. Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression. 2005 Br. J. Pharmacol. pmid:16025141
Xie DS and Xie YT [Role of platelet activating factor in hepatorenal syndrome]. 2005 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:16045031
Marathe GK et al. Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage. 2005 J. Biol. Chem. pmid:16115894
Chang GT et al. Purification and characterization of a new anticoagulant protein, PP27, from placenta. 2005 Thromb. Res. pmid:16122555
Ezoulin MJ et al. Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells. 2005 Neurosci. Lett. pmid:16095823
Burgos RA et al. 14-deoxyandrographolide as a platelet activating factor antagonist in bovine neutrophils. 2005 Planta Med. pmid:16041644
Caplan MS et al. The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis. 2005 Semin. Pediatr. Surg. pmid:16084401
Shindou H et al. Priming effect of lipopolysaccharide on acetyl-coenzyme A:lyso-platelet-activating factor acetyltransferase is MyD88 and TRIF independent. 2005 J. Immunol. pmid:16002720
Mann NS and Leung JW Pathogenesis of esophageal rings in eosinophilic esophagitis. 2005 Med. Hypotheses pmid:15617859
Cheng L et al. Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis. 2005 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:15890711
Qu XW et al. Tetrahydrobiopterin prevents platelet-activating factor-induced intestinal hypoperfusion and necrosis: Role of neuronal nitric oxide synthase. 2005 Crit. Care Med. pmid:15891335
Gilli UO et al. Human polymorphonuclear neutrophils are recruited by porcine chemokines acting on CXC chemokine receptor 2, and platelet-activating factor. 2005 Transplantation pmid:15912099
Park EJ et al. Dietary ganglioside decreases cholesterol content, caveolin expression and inflammatory mediators in rat intestinal microdomains. 2005 Glycobiology pmid:15917432
Owen JS et al. Stress-induced platelet-activating factor synthesis in human neutrophils. 2005 Biochim. Biophys. Acta pmid:15863359
Göggel R and Uhlig S The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema. 2005 Eur. Respir. J. pmid:15863642
Martínez-Cócera C et al. Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study. 2005 J Investig Allergol Clin Immunol pmid:15864879
Yeh JH et al. 2-O-methyl PAF as a Ca2+ mobilizer in Madin Darby canine kidney cells. 2005 Life Sci. pmid:15878360
Medvedev IN and GromnatsiÄ­ NI [The influence of nebivolol on thrombocyte aggregation in patients with arterial hypertension with metabolic sydrome]. 2005 Klin Med (Mosk) pmid:15881638
Rastelli VM et al. Influence of insulin on the microvascular response to inflammatory mediators in neonatal streptozotocin diabetic rats. 2005 Inflamm. Res. pmid:15883740
Ko HM et al. Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis. 2005 FEBS Lett. pmid:15848174
Hardy P et al. New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy. 2005 Prostaglandins Leukot. Essent. Fatty Acids pmid:15850712
Chen LW et al. Different pathways leading to activation of extracellular signal-regulated kinase and p38 MAP kinase by formyl-methionyl-leucyl-phenylalanine or platelet activating factor in human neutrophils. 2005 J. Biomed. Sci. pmid:15917990
Vinson SM et al. Neutrophil adherence to bladder microvascular endothelial cells following platelet-activating factor acetylhydrolase inhibition. 2005 J. Pharmacol. Exp. Ther. pmid:15937147
Sumita C et al. Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophages. 2005 FEBS Lett. pmid:16004986
Dong J et al. [Effect of platelet-activating factor on long-term potentiation in rat hippocampal slices]. 2005 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21171322
Ou-Yang XY et al. [Inhibitory effect of ginkgolide B on angiogenesis in chronic inflammation]. 2005 Yao Xue Xue Bao pmid:16011257
Estellés R et al. Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neutrophil recruitment in vivo. 2005 J. Leukoc. Biol. pmid:15944212
Zhao T and Bokoch GM Critical role of proline-rich tyrosine kinase 2 in reversion of the adhesion-mediated suppression of reactive oxygen species generation by human neutrophils. 2005 J. Immunol. pmid:15944312
McLarnon JG et al. Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients. 2005 J. Neurosci. Res. pmid:15948178
Ozger S et al. Effects of platelet-activating factor on nitrergic transmission in rabbit corpus cavernosum. 2005 Int. J. Urol. pmid:15985080
Cao HC et al. Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis. 2005 World J. Gastroenterol. pmid:16437644
Asada Y [Inflammatory and immune responses in arterial thrombus formation]. 2005 Rinsho Ketsueki pmid:16447700
Kira J [Multiple sclerosis]. 2005 Rinsho Shinkeigaku pmid:16447761
Rubin BB et al. Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity. 2005 J. Biol. Chem. pmid:15475363
Zinchuk O et al. Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis. 2005 Mol. Vis. pmid:15735601
Lang PA et al. Stimulation of erythrocyte ceramide formation by platelet-activating factor. 2005 J. Cell. Sci. pmid:15741229
Sheppard FR et al. Clinically relevant osmolar stress inhibits priming-induced PMN NADPH oxidase subunit translocation. 2005 J Trauma pmid:15824651
Leveau P et al. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant. 2005 Biochem. Pharmacol. pmid:15826603
Kumar S and Sharma A Platelet activating factor improves the in vitro penetration of zona free hamster eggs by buffalo (Bubalus bubalis) spermatozoa. 2005 Theriogenology pmid:15763101
Asai Y Formation of spherical micelles composed of the novel platelet activating factor receptor antagonist, E5880. 2005 Pharmazie pmid:15801673
Nacken W et al. S100A9 deficiency alters adenosine-5'-triphosphate induced calcium signalling but does not generally interfere with calcium and zinc homeostasis in murine neutrophils. 2005 Int. J. Biochem. Cell Biol. pmid:15778088
Minnear FL et al. Sphingosine 1-phosphate prevents platelet-activating factor-induced increase in hydraulic conductivity in rat mesenteric venules: pertussis toxin sensitive. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15778280
Perry SW et al. HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis. 2005 J. Immunol. pmid:15778398
Ishiura Y et al. In vivo PAF-induced airway eosinophil accumulation reduces bronchial responsiveness to inhaled histamine. 2005 Prostaglandins Other Lipid Mediat. pmid:15789611
Ivanov AI et al. Albumin is not an irreplaceable carrier for amphipathic mediators of thermoregulatory responses to LPS: compensatory role of alpha1-acid glycoprotein. 2005 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:15576666
Denizot Y et al. Platelet-activating factor does not stimulate cAMP formation from immature forms of freshly isolated leukaemic blasts. 2005 Leuk. Lymphoma pmid:15621790
Meyer MC et al. Calcium-independent phospholipase A2 is regulated by a novel protein kinase C in human coronary artery endothelial cells. 2005 Am. J. Physiol., Cell Physiol. pmid:15643055
Granger J and Remick D Acute pancreatitis: models, markers, and mediators. 2005 Shock pmid:16374372
Wang CP et al. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats]. 2005 Zhonghua Yi Xue Za Zhi pmid:16409839
Zhang Q et al. Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. 2005 J. Clin. Invest. pmid:16184199
Pexa A and Deussen A Modulation of ecto-5'-nucleotidase by phospholipids in human umbilical vein endothelial cells (HUVEC). 2005 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16200394
Karantonis HC et al. Synthesis and biological evaluation of novel steroid-modified ether phospholipids. 2005 Chem. Phys. Lipids pmid:16202400
Antonopoulou S et al. Bioactive polar lipids from Chroococcidiopsis sp. (Cyanobacteria). 2005 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:16198133
Melo RC et al. Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. 2005 Traffic pmid:16138901
Ueda Y et al. Antianaphylactic and antipruritic effects of the flowers of Impatiens textori MIQ. 2005 Biol. Pharm. Bull. pmid:16141562
Chang GT et al. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation. 2005 J Ethnopharmacol pmid:16125889
Iversen VV et al. Platelet activating factor (PAF) increases plasma protein extravasation and induces lowering of interstitial fluid pressure (P) in rat skin. 2005 Acta Physiol. Scand. pmid:16128692
Hu G et al. Isoflurane prevents platelets from enhancing neutrophil-induced coronary endothelial dysfunction. 2005 Anesth. Analg. pmid:16243978
Okumura N et al. Platelet-activating factor in human normal tears. 2005 Curr. Eye Res. pmid:16251126
Ko HM et al. Platelet-activating factor induces matrix metalloproteinase-9 expression through Ca(2+)- or PI3K-dependent signaling pathway in a human vascular endothelial cell line. 2005 FEBS Lett. pmid:16288746
Ward JR et al. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. 2005 Thromb. Haemost. pmid:16270639
Walz PH et al. Platelet function and association of bovine viral diarrhea virus with platelets of persistently infected cattle. 2005 Am. J. Vet. Res. pmid:16273905
Shargall Y et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment. 2005 J. Heart Lung Transplant. pmid:16210120
Fragopoulou E et al. Characterization of acetyl-CoA: lyso-PAF acetyltransferase of human mesangial cells. 2005 Mediators Inflamm. pmid:16258193
Shibamoto T et al. Involvement of platelet-activating factor and leukotrienes in anaphylactic segmental venoconstriction in ovalbumin sensitized guinea pig livers. 2005 Prostaglandins Other Lipid Mediat. pmid:16303618
Vieira-de-Abreu A et al. Anti-allergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influx. 2005 Int. Immunopharmacol. pmid:16275631